Cargando…

Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed

Raising awareness about primary TAS, a rare and aggressive mesenchymal tumor, is important so that early diagnosis and undelayed radical surgery along with complementary radiation are possible. Extending the existing knowledge on the course and final outcome of the disease may help identify the best...

Descripción completa

Detalles Bibliográficos
Autores principales: Kehagias, Dimitrios, Kostopoulou, Eirini, Ravazoula, Panagiota, Panagopoulos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813081/
https://www.ncbi.nlm.nih.gov/pubmed/33489155
http://dx.doi.org/10.1002/ccr3.3492
_version_ 1783637787513192448
author Kehagias, Dimitrios
Kostopoulou, Eirini
Ravazoula, Panagiota
Panagopoulos, Konstantinos
author_facet Kehagias, Dimitrios
Kostopoulou, Eirini
Ravazoula, Panagiota
Panagopoulos, Konstantinos
author_sort Kehagias, Dimitrios
collection PubMed
description Raising awareness about primary TAS, a rare and aggressive mesenchymal tumor, is important so that early diagnosis and undelayed radical surgery along with complementary radiation are possible. Extending the existing knowledge on the course and final outcome of the disease may help identify the best treatment approach to improve survival.
format Online
Article
Text
id pubmed-7813081
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78130812021-01-22 Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed Kehagias, Dimitrios Kostopoulou, Eirini Ravazoula, Panagiota Panagopoulos, Konstantinos Clin Case Rep Case Reports Raising awareness about primary TAS, a rare and aggressive mesenchymal tumor, is important so that early diagnosis and undelayed radical surgery along with complementary radiation are possible. Extending the existing knowledge on the course and final outcome of the disease may help identify the best treatment approach to improve survival. John Wiley and Sons Inc. 2020-11-11 /pmc/articles/PMC7813081/ /pubmed/33489155 http://dx.doi.org/10.1002/ccr3.3492 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Kehagias, Dimitrios
Kostopoulou, Eirini
Ravazoula, Panagiota
Panagopoulos, Konstantinos
Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title_full Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title_fullStr Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title_full_unstemmed Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title_short Thyroid angiosarcoma (TAS) — A rare diagnosis not to be missed
title_sort thyroid angiosarcoma (tas) — a rare diagnosis not to be missed
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813081/
https://www.ncbi.nlm.nih.gov/pubmed/33489155
http://dx.doi.org/10.1002/ccr3.3492
work_keys_str_mv AT kehagiasdimitrios thyroidangiosarcomatasararediagnosisnottobemissed
AT kostopouloueirini thyroidangiosarcomatasararediagnosisnottobemissed
AT ravazoulapanagiota thyroidangiosarcomatasararediagnosisnottobemissed
AT panagopouloskonstantinos thyroidangiosarcomatasararediagnosisnottobemissed